Alcon announces FDA approval of TRYPTYR for Dry Eye Disease
In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 1
Alcon
In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 1